- Home
- ELWS vs ALZN Comparison
ELWS vs ALZN Comparison
Compare ELWS & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- ALZN
- Stock Information
- Founded
- ELWS 2018
- ALZN 2016
- Country
- ELWS Japan
- ALZN United States
- Employees
- ELWS N/A
- ALZN N/A
- Industry
- ELWS
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- ELWS
- ALZN Health Care
- Exchange
- ELWS Nasdaq
- ALZN Nasdaq
- Market Cap
- ELWS 6.2M
- ALZN 6.1M
- IPO Year
- ELWS 2023
- ALZN 2021
- Fundamental
- Price
- ELWS $1.89
- ALZN $0.96
- Analyst Decision
- ELWS
- ALZN Strong Buy
- Analyst Count
- ELWS 0
- ALZN 1
- Target Price
- ELWS N/A
- ALZN $20.00
- AVG Volume (30 Days)
- ELWS 14.0K
- ALZN 213.1K
- Earning Date
- ELWS 03-03-2025
- ALZN 03-10-2025
- Dividend Yield
- ELWS N/A
- ALZN N/A
- EPS Growth
- ELWS N/A
- ALZN N/A
- EPS
- ELWS N/A
- ALZN N/A
- Revenue
- ELWS $2,292,406.00
- ALZN N/A
- Revenue This Year
- ELWS N/A
- ALZN $322.64
- Revenue Next Year
- ELWS N/A
- ALZN N/A
- P/E Ratio
- ELWS N/A
- ALZN N/A
- Revenue Growth
- ELWS 404.13
- ALZN N/A
- 52 Week Low
- ELWS $1.04
- ALZN $0.64
- 52 Week High
- ELWS $8.68
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- ELWS 43.93
- ALZN 50.44
- Support Level
- ELWS $2.00
- ALZN $0.95
- Resistance Level
- ELWS $2.34
- ALZN $1.13
- Average True Range (ATR)
- ELWS 0.26
- ALZN 0.10
- MACD
- ELWS 0.03
- ALZN 0.01
- Stochastic Oscillator
- ELWS 24.45
- ALZN 44.39
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.